![Dong-Hui Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong-Hui Kim
Finanzdirektor/CFO bei
GI INNOVATION, INC.
Vermögen: 8 069 $ am 31.08.2026
Profil
Dong-Hui Kim is currently Managing Director & Head-Financial Planning at GI Innovation, Inc. since 2024 and serves as an Independent Director at Hana Thirty-six Special Purpose Acquisition Co. Former positions include Manager-Accounting Team at Hana Bank and Manager-Financial Planning Department at Hana Financial Group, Inc. from 2013 to 2015.
Education includes an undergraduate degree from Yonsei University, conferred in 2007.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.08.2026 | 1 350 ( 0 % ) | 8 069 $ | 31.08.2026 |
Aktive Positionen von Dong-Hui Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| GI INNOVATION, INC. | Finanzdirektor/CFO | 01.09.2024 |
Ehemalige bekannte Positionen von Dong-Hui Kim
| Unternehmen | Position | Ende |
|---|---|---|
| HANA FINANCIAL GROUP INC. | Corporate Officer/Principal | 01.12.2015 |
Hana Bank
 Hana Bank Regional BanksFinance Provides banking services | Comptroller/Controller/Auditor | - |
Ausbildung von Dong-Hui Kim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Hana Bank
Hana Bank Regional BanksFinance Provides banking services | Finance |
Hana Financial Group, Inc.
 Hana Financial Group, Inc. Major BanksFinance Operates as a bank | Finance |
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GI Innovation, Inc.
 GI Innovation, Inc. BiotechnologyHealth Technology Engages in research and development of immunotherapy drugs based on fusion proteins | Health Technology |
